Education
About Us
Working with TipRanks
Follow Us
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
RESEARCH TOOLSreports
8622 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.12 - HK$0.46
Previous CloseN/A
Volume952.00K
Average Volume (3M)316.13K
Market Cap
HK$192.68M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Aug 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding500,472,000
10 Day Avg. Volume208,000
30 Day Avg. Volume316,133
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8622 FAQ
What was Huakang Biomedical Holdings Company Limited’s price range in the past 12 months?
Huakang Biomedical Holdings Company Limited lowest stock price was HK$0.12 and its highest was HK$0.46 in the past 12 months.
What is Huakang Biomedical Holdings Company Limited’s market cap?
Huakang Biomedical Holdings Company Limited’s market cap is HK$192.68M.
When is Huakang Biomedical Holdings Company Limited’s upcoming earnings report date?
Huakang Biomedical Holdings Company Limited’s upcoming earnings report date is Aug 12, 2025 which is in 9 days.
How were Huakang Biomedical Holdings Company Limited’s earnings last quarter?
Currently, no data Available
Is Huakang Biomedical Holdings Company Limited overvalued?
According to Wall Street analysts Huakang Biomedical Holdings Company Limited’s price is currently Overvalued.
Does Huakang Biomedical Holdings Company Limited pay dividends?
Huakang Biomedical Holdings Company Limited does not currently pay dividends.
What is Huakang Biomedical Holdings Company Limited’s EPS estimate?
Huakang Biomedical Holdings Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Huakang Biomedical Holdings Company Limited have?
Huakang Biomedical Holdings Company Limited has 500,472,000 shares outstanding.
What happened to Huakang Biomedical Holdings Company Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Huakang Biomedical Holdings Company Limited?
Currently, no hedge funds are holding shares in HK:8622
Huakang Biomedical Holdings Company Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
178.98%
12-Months-Change
Fundamentals
Return on Equity
-7.93%
Trailing 12-Months
Asset Growth
-3.48%
Trailing 12-Months
Company Description
Huakang Biomedical Holdings Company Limited
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; auxiliary reproductive supplies and equipment; and healthcare products and supplements under the Nutronic brand to customers, as well as through online and offline platforms and channels. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is headquartered in Wan Chai, Hong Kong.
Technical Analysis
Extrawell Pharmaceutical Holdings Limited
―
China NT Pharma Group Co., Ltd.
―
Kontafarma China Holdings Ltd
―
PuraPharm Corp. Ltd.
―
Fusen Pharmaceutical Co., Ltd.
―